[Tunehead54]

Too bad these slimeballs didn't check their facts before dumping their stock - the drug is actually showing real promise - Imklone's study design was being faulted not the drug itself.

See a recent article here: Controversy hides drug's pluses - St. Petersburg Times - St. Petersburg, FL - Jul 30, 2002 - WES ALLISON & KRIS HUNDLEY

---

[Tunehead54]

Oops! Make that "ImClone Systems" (IMCL) - holding up better than Enron or Global Crossing ...